The Biguanides Market Size & Share is the overall measurement of the market for drugs belonging to this class. The market is mainly segmented by drug type, dosage form, formulation, and distribution channel.
By Drug Type (Branded, Generic)
- Branded Biguanides are those that are marketed under a specific brand name by a pharmaceutical company. These drugs are usually more expensive than their generic counterparts due to the branding and marketing costs associated with them. Generic Biguanides, on the other hand, are the same drug as the branded ones but are sold under their chemical name. They are generally more affordable and make up a significant portion of the market share.
By Dosage Form (Tablets, Oral Solutions)
- Biguanides are available in various dosage forms, with tablets and oral solutions being the most common. Tablets are preferred by most patients due to their convenience and ease of administration. Oral solutions are used for patients who have difficulty swallowing tablets or for those who prefer liquid formulations.
By Formulation (Immediate-release, Extended-release)
- Biguanides come in different formulations, including immediate-release and extended-release formulations. Immediate-release formulations are designed to release the drug into the bloodstream quickly, providing fast relief of symptoms. Extended-release formulations, on the other hand, release the drug slowly over time, allowing for less frequent dosing and improved patient adherence.
By Distribution Channel (Hospital, Retail, Online Pharmacies)
- Biguanides are distributed through various channels, including hospitals, retail pharmacies, and online pharmacies. Hospitals often stock these drugs for inpatient use or for outpatient prescriptions. Retail pharmacies are the most common distribution channel for patients to obtain their medications. Online pharmacies are gaining popularity due to the convenience of ordering medications from the comfort of one's home.